文献速递肝胆胰外科围术期管理与 ERAS

微创远端胰腺切除术对衰弱患者获益最大

Minimally invasive distal pancreatectomy: greatest benefit for the frail.
PubMed 文献 · Surg Endosc · 2017-05-10

该研究基于2014年NSQIP胰腺数据库分析1038例远端胰腺切除术,比较微创与开腹手术的Clavien IV级并发症。非衰弱患者中微创与开腹并发症率相似,而衰弱患者微创并发症率更低,且衰弱程度加重与并发症增加相关。结论提示微创入路可能降低衰弱患者风险。

要点

  • 衰弱患者行微创远端胰腺切除术较开腹手术Clavien IV级并发症更低。
  • 衰弱程度加重与术后并发症增加相关。
  • 非衰弱患者微创与开腹手术并发症率相似。

核心结论

  • 对衰弱患者,微创远端胰腺切除术相比开腹手术与更低的Clavien IV级并发症风险相关,尤其良性病变。
  • 微创入路可能减轻衰弱患者的风险。

研究设计与样本

  • 回顾性分析2014年NSQIP胰腺靶向数据库,共纳入1038例远端胰腺切除术患者。
  • 使用11项术前变量构成的改良衰弱指数(mFI)评估衰弱,将患者分为非衰弱(mFI=0)和衰弱(mFI>0),衰弱再分为轻度(mFI 1或2)和重度(mFI=3)。

主要发现

  • 总体Clavien IV级并发症发生率为4.6%,死亡率为1.1%。
  • 非衰弱患者中,微创、开腹、微创中转开腹的Clavien IV级并发症率分别为2.3%、2.3%、4.9%(p=0.6)。
  • 衰弱患者中,微创、开腹、微创中转开腹的Clavien IV级并发症率分别为2.4%、8.3%、11.5%(p=0.007)。
  • 衰弱程度加重与并发症增加相关:非衰弱2.5%、轻度衰弱6.3%、重度衰弱20%(p=0.005)。

临床怎么用

  • 对于衰弱患者,可优先考虑微创远端胰腺切除术以降低严重并发症风险。
  • 术前应评估衰弱程度(如mFI),以识别高风险患者并指导手术方式选择。

局限性

  • 研究为回顾性数据库分析,可能存在选择偏倚和混杂因素。
  • 重度衰弱患者样本量小(mFI=3仅5例),结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The benefits of minimally invasive distal pancreatectomy (MIDP) over open surgery continue to be investigated. Frailty is a known predictor of postoperative outcome. We hypothesized that the benefit of minimally invasive distal pancreatectomy is the greatest for the frailest of patients. METHODS: Data from the pancreas-targeted National Surgical Quality Improvement Program (NSQIP) database for 2014 were reviewed. A modified frailty index (mFI) with 11 preoperative variables previously validated for use in NSQIP was used to determine the correlation between frailty and postoperative outcomes, including Clavien grade IV complications. Patients were classified into non-frail (mFI = 0) or frail (mIF > 0), in which they were subclassified into mildly frail (mFI 1 or 2) or severely frail (mFI = 3). RESULTS: A total of 1,038 distal pancreatectomies (DP) were included in the analysis, of which 387 were minimally invasive (MIDP: laparoscopic: 285, robotic: 102), 558 open DP (ODP), and 93 MIDP converted to open (MIDPcODP: laparoscopic: 80, robotic: 13). More than 90% of patients had an mFI of 0 or 1 (mFI 0 = 473 (45.6%), 1 = 466 (44.9%), 2 = 94 (9.1%), and 3 = 5 (0.5%), respectively). Overall, 4.6% of patients experienced Clavien grade IV complications and 1.1% a mortality. Non-frail patients experienced a similar rate of grade IV Clavien complications with MIDP vs. ODP vs. MIDPcOP (2.3 vs. 2.3 vs. 4.9%; p = 0.6), whereas frail patients (mFI > 0) had a lower rate of complications with MIDP (2.4 vs. 8.3 vs. 11.5; p = 0.007). Worsening frailty correlated with an increase in complications (non-frail: 2.5%; mildly frail: 6.3%; severely frail: 20%; p = 0.005). CONCLUSION: MIDP is associated with a lower risk of Clavien grade IV complications compared to ODP for frail patients, especially for benign disease. Thus, minimally invasive approach may mitigate risk in frail patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Konstantinidis IT, Lewis A, Lee B, et al. Minimally invasive distal pancreatectomy: greatest benefit for the frail. Surg Endosc. 2017. PMID: 28493165. doi:10.1007/s00464-017-5593-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。